215 related articles for article (PubMed ID: 20005748)
21. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
22. Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
Soave A; Riethdorf S; Dahlem R; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M
BJU Int; 2017 Jun; 119(6):854-861. PubMed ID: 28182321
[TBL] [Abstract][Full Text] [Related]
23. Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study.
Bassi PF; Bongiovanni L; Racioppi M; Volpe A; D'Agostino D; Gardi M; ;
Urol Oncol; 2011; 29(6):698-702. PubMed ID: 19959381
[TBL] [Abstract][Full Text] [Related]
24. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Catto JW; Abbod MF; Linkens DA; Larré S; Rosario DJ; Hamdy FC
Clin Cancer Res; 2009 May; 15(9):3150-5. PubMed ID: 19336522
[TBL] [Abstract][Full Text] [Related]
25. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
26. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
27. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Gupta A; Lotan Y; Bastian PJ; Palapattu GS; Karakiewicz PI; Raj GV; Schoenberg MP; Lerner SP; Sagalowsky AI; Shariat SF;
Urology; 2008 Feb; 71(2):302-7. PubMed ID: 18308108
[TBL] [Abstract][Full Text] [Related]
30. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
[TBL] [Abstract][Full Text] [Related]
31. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
[TBL] [Abstract][Full Text] [Related]
32. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
Scosyrev E; Yao J; Messing E
Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
[TBL] [Abstract][Full Text] [Related]
33. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
[TBL] [Abstract][Full Text] [Related]
34. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
[TBL] [Abstract][Full Text] [Related]
36. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases.
Pruthi RS; Nielsen ME; Nix J; Smith A; Schultz H; Wallen EM
J Urol; 2010 Feb; 183(2):510-4. PubMed ID: 20006884
[TBL] [Abstract][Full Text] [Related]
37. A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
Soave A; Riethdorf S; Dahlem R; von Amsberg G; Minner S; Weisbach L; Engel O; Fisch M; Pantel K; Rink M
Int J Cancer; 2017 Jan; 140(2):381-389. PubMed ID: 27668704
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
[TBL] [Abstract][Full Text] [Related]
39. External validation of a biomarker based pre-cystectomy algorithm to predict nonorgan confined urothelial cancers.
Margel D; Bostrom P; Baniel J; Yossepowitch O; Zlotta A; Fleshner N
J Urol; 2012 Mar; 187(3):840-4. PubMed ID: 22245328
[TBL] [Abstract][Full Text] [Related]
40. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]